Drugs / SIM1910-09
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05200728 | Dec 2021 → Mar 2023 | brain edema, ischemic stroke | Jiangsu Simcere Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SIM1910-09 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05200728 ↗ |
| Route | Intravenous | “SIM1910-09 will be administered by IV bolus infusion over a 30-min.” NCT05200728 ↗ |